Advertisement News Archives - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

News

November 25, 2022

Junshi Biosciences seeks UK’s marketing authorisation for toripalimab

Shanghai Junshi Biosciences has submitted a marketing authorization application (MAA) for its toripalimab to the Medicines and Healthcare products Regulatory Agency (MHRA) of the UK.

Junshi Biosciences seeks UK’s marketing authorisation for toripalimab